A healthcare professional administers an injection to an elderly patient in a hospital setting.
Stéf -b. (Pexels) / Pexels License
Clinical Trials/October 7, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes — RECRUITING, PHASE2. Interventions: Tirzepatide 2.5mg weekly, Placebo injection (normal saline). Locations: Sydney, New South Wales, Australia. This study will examine the effects of Tirzepatide (TZP), a glucagon-like pe...Source
  • Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes — RECRUITING, NA. Interventions: diverse carbohydrate diet, moderate carbohydrate diet. Locations: Nanjing, Jiangsu, China. This multicenter, randomized, controlled, open-label clinical trial aims to evaluate the effects...Source
  • Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions — RECRUITING, NA. Interventions: Making Care Fit tool, Care as usual. Locations: Leiden, South Holland, Netherlands | Rotterdam, South Holland, Netherlands. The goal of this clinical study is to assess differences in coll...Source
  • The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action — RECRUITING, PHASE2. Interventions: Metformin. Locations: Indianapolis, Indiana, United States. Ovwerweight and obesity prevalence in persons with T1D has increased, which further complicates management and risk for comp...Source
  • A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 — RECRUITING, PHASE1. Interventions: Portal Insulin U-500, Portal Insulin U-500, Portal Insulin U-500. Locations: Chula Vista, California, United States. The goal of this clinical trial is to assess the safety of a new U5...Source
  • Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults — RECRUITING. Locations: Pavia, Pavia, Italy. After obtaining informed consent, the investigators will recruit 75 patients with T1DM and 75 with LADA with an age ≥ 18 years and ≤ 75 years, of both sexes. All patients will...Source
  • Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge — RECRUITING, NA. Interventions: Libre 3 Plus Continuous Glucose Monitor, Dexcom G7 Continuous Glucose Monitor. Locations: Nashville, Tennessee, United States. This study aims to improve patient awareness of the utility o...Source
  • Diabetes in African Youth — RECRUITING, PHASE4. Interventions: Libre 2, Device for SMBG and Libre Pro. Locations: Minneapolis, Minnesota, United States. This RCT aims to improve T1D care in East African children and young adults by testing the hyp...Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.